Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bacterial Infections and Mycoses

  Free Subscription


25.02.2019

7 Antimicrob Agents Chemother
1 BMJ
1 Chest
1 Clin Infect Dis
1 Diagn Microbiol Infect Dis
1 Eur J Clin Microbiol Infect Dis
1 Infect Immun
3 J Antimicrob Chemother
1 J Bacteriol
1 J Infect Dis
1 J Med Chem
4 JAMA
4 Lancet
2 Lancet Glob Health
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
6 PLoS One
2 PLoS Pathog
5 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. DENEGA I, d'Enfert C, Bachellier-Bassi S
    Candida albicans biofilms are generally devoid of persister cells.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01979.
    PubMed     Text format     Abstract available

  2. VERREAULT D, Ennis J, Whaley K, Killeen SZ, et al
    Effective Treatment of Staphylococcal Enterotoxin B (SEB) Aerosol Intoxication in Rhesus Macaques using two parentally-administered High Affinity Monoclonal Antibodies.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02049.
    PubMed     Text format     Abstract available

  3. BAINES SL, Jensen SO, Firth N, Goncalves da Silva A, et al
    Remodelling of pSK1 Family Plasmids and Enhanced Chlorhexidine Tolerance in a Dominant Hospital Lineage of Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02356.
    PubMed     Text format     Abstract available

  4. WARRILOW AG, Nishimoto AT, Parker JE, Price CL, et al
    The Evolution of Azole Resistance in Candida albicans Sterol 14alpha-Demethylase (CYP51) through Incremental Amino Acid Substitutions.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02586.
    PubMed     Text format     Abstract available

  5. GINGRAS H, Patron K, Bhattacharya A, Leprohon P, et al
    Gain and loss of function screens coupled to next generation sequencing for antibiotic mode of action and resistance studies in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02381.
    PubMed     Text format     Abstract available

  6. LIESE J, Schule L, Oberhettinger P, Tschorner L, et al
    Expansion of Vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole genome-based outbreak investigation.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01978.
    PubMed     Text format     Abstract available

  7. XU J, Wang B, Fu L, Zhu H, et al
    In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02155.
    PubMed     Text format     Abstract available


    BMJ

  8. SEEDAT F, Geppert J, Stinton C, Patterson J, et al
    Universal antenatal screening for group B streptococcus may cause more harm than good.
    BMJ. 2019;364:l463.
    PubMed     Text format    


    Chest

  9. PAONESSA JR, Shah RD, Pickens CI, Lizza BD, et al
    Rapid detection of methicillin-resistant Staphylococcus aureus in bronchoalveolar lavage: A pilot randomized controlled trial.
    Chest. 2019 Feb 15. pii: S0012-3692(19)30156-4. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  10. REEKIE J, Donovan B, Guy R, Hocking JS, et al
    Risk of ectopic pregnancy and tubal infertility following gonorrhoea and chlamydia infections.
    Clin Infect Dis. 2019 Feb 18. pii: 5335756. doi: 10.1093.
    PubMed     Text format     Abstract available


    Diagn Microbiol Infect Dis

  11. WU X, Qin X, Huang J, Wang F, et al
    Determining the in vitro susceptibility of Neisseria gonorrhoeae isolates from 8 cities in Guangdong Province through an improved microdilution method.
    Diagn Microbiol Infect Dis. 2018;92:325-331.
    PubMed     Text format     Abstract available


    Eur J Clin Microbiol Infect Dis

  12. NY S, Kozlov R, Dumpis U, Edquist P, et al
    Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia.
    Eur J Clin Microbiol Infect Dis. 2018;37:2347-2354.
    PubMed     Text format     Abstract available


    Infect Immun

  13. KIM JH, Chaurasia AK, Batool N, Ko KS, et al
    An alternative enzyme protection assay to overcome the drawbacks of gentamicin protection assay for measuring entry and intracellular survival of Staphylococci.
    Infect Immun. 2019 Feb 19. pii: IAI.00119-19. doi: 10.1128/IAI.00119.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  14. HU Y, Pertinez H, Liu Y, Davies G, et al
    Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
    J Antimicrob Chemother. 2019 Feb 20. pii: 5353164. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. FARHAT MR, Sixsmith J, Calderon R, Hicks ND, et al
    Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    J Antimicrob Chemother. 2019 Feb 21. pii: 5359497. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. KANG J, Dietz MJ, Hughes K, Xing M, et al
    Silver nanoparticles present high intracellular and extracellular killing against Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 18. pii: 5333167. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Bacteriol

  17. FAVAZZO LJ, Gill AL, Farnsworth CW, Mooney RA, et al
    Response of nor and nos contributes to Staphylococcus aureus virulence and metabolism.
    J Bacteriol. 2019 Feb 19. pii: JB.00107-19. doi: 10.1128/JB.00107.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. BUURMAN ET, Timofeyeva Y, Gu J, Kim JH, et al
    A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization.
    J Infect Dis. 2019 Feb 19. pii: 5336091. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Chem

  19. WANG X, Zeng Y, Sheng L, Larson P, et al
    A Cinchona Alkaloid Antibiotic that Appears to Target ATP Synthase in Streptococcus pneumoniae.
    J Med Chem. 2019 Feb 19. doi: 10.1021/acs.jmedchem.8b01353.
    PubMed     Text format     Abstract available


    JAMA

  20. RODRIGUEZ-BANO J, Gutierrez-Gutierrez B, Kahlmeter G
    Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections.
    JAMA. 2019;321:612-613.
    PubMed     Text format    

  21. HSU HE, Wang R, Jentzsch MS, Jin R, et al
    Association Between Value-Based Incentive Programs and Catheter-Associated Urinary Tract Infection Rates in the Critical Care Setting.
    JAMA. 2019;321:509-511.
    PubMed     Text format    

  22. PREVEL R, Berdai D, Boyer A
    Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections.
    JAMA. 2019;321:613.
    PubMed     Text format    

  23. HARRIS PNA, Tambyah P, Paterson DL
    Antibiotics for Ceftriaxone Resistant Gram-Negative Bacterial Bloodstream Infections-Reply.
    JAMA. 2019;321:613.
    PubMed     Text format    


    Lancet

  24. THE LANCET
    Abandoning the stigma of leprosy.
    Lancet. 2019;393:378.
    PubMed     Text format    

  25. OLSAVSZKY V, Geraud C
    Liaison leads to solitary syphilitic chancre on the neck.
    Lancet. 2018;392:2397.
    PubMed     Text format    

  26. VAN DER HEIJDE D, Baraliakos X, Gensler LS, Maksymowych WP, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2378-2387.
    PubMed     Text format     Abstract available

  27. MEASE P, Coates LC, Helliwell PS, Stanislavchuk M, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2367-2377.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  28. LUNG T, Marks GB, Nhung NV, Anh NT, et al
    Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.
    Lancet Glob Health. 2019;7:e376-e384.
    PubMed     Text format     Abstract available

  29. WINGFIELD T, Verguet S
    Active case finding in tuberculosis-affected households: time to scale up.
    Lancet Glob Health. 2019;7:e296-e298.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  30. PEDATI C, Koirala S, Safranek T, Buss BF, et al
    Campylobacteriosis Outbreak Associated with Contaminated Municipal Water Supply - Nebraska, 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:169-173.
    PubMed     Text format     Abstract available


    N Engl J Med

  31. COX E, Nambiar S, Baden L
    Needed: Antimicrobial Development.
    N Engl J Med. 2019;380:783-785.
    PubMed     Text format    


    PLoS One

  32. YAN RL, Ye YF, Fan QY, Huang YH, et al
    Chlamydia trachomatis infection among patients attending sexual and reproductive health clinics: A cross-sectional study in Bao'an District, Shenzhen, China.
    PLoS One. 2019;14:e0212292.
    PubMed     Text format     Abstract available

  33. BASAS J, Palau M, Gomis X, Almirante B, et al
    Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.
    PLoS One. 2019;14:e0212426.
    PubMed     Text format     Abstract available

  34. ADESOKAN HK, Streicher EM, van Helden PD, Warren RM, et al
    Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria.
    PLoS One. 2019;14:e0211637.
    PubMed     Text format     Abstract available

  35. REIS-SANTOS B, Shete P, Bertolde A, Sales CM, et al
    Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates.
    PLoS One. 2019;14:e0212617.
    PubMed     Text format     Abstract available

  36. DOULLA BE, Squire SB, MacPherson E, Ngadaya ES, et al
    Routine surveillance for the identification of drug resistant Tuberculosis in Tanzania: A cross-sectional study of stakeholders' perceptions.
    PLoS One. 2019;14:e0212421.
    PubMed     Text format     Abstract available

  37. RODRIGUEZ AE, Bogart C, Gilbert CM, McCullers JA, et al
    Enhanced IL-1beta production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae.
    PLoS One. 2019;14:e0212236.
    PubMed     Text format     Abstract available


    PLoS Pathog

  38. SHEN Q, Beucler MJ, Ray SC, Rappleye CA, et al
    Macrophage activation by IFN-gamma triggers restriction of phagosomal copper from intracellular pathogens.
    PLoS Pathog. 2018;14:e1007444.
    PubMed     Text format     Abstract available

  39. AZARIAN T, Mitchell PK, Georgieva M, Thompson CM, et al
    Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci.
    PLoS Pathog. 2018;14:e1007438.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. RELMAN DA, Lipsitch M
    Microbiome as a tool and a target in the effort to address antimicrobial resistance.
    Proc Natl Acad Sci U S A. 2018;115:12902-12910.
    PubMed     Text format     Abstract available

  41. BAKER SJ, Payne DJ, Rappuoli R, De Gregorio E, et al
    Technologies to address antimicrobial resistance.
    Proc Natl Acad Sci U S A. 2018;115:12887-12895.
    PubMed     Text format     Abstract available

  42. SEVILLA JP, Bloom DE, Cadarette D, Jit M, et al
    Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.
    Proc Natl Acad Sci U S A. 2018;115:12911-12919.
    PubMed     Text format     Abstract available

  43. DUNCAN TM
    Turbine enzyme's structure in the crosshairs to target tuberculosis.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1900798116.
    PubMed     Text format    

  44. KLUGMAN KP, Black S
    Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.
    Proc Natl Acad Sci U S A. 2018;115:12896-12901.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: